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Abstract 
Purpose: To investigate the effect of Ecklonia kurome extract (EKE) on thyroid hormone concentrations 
in male mice. 
Methods: Mice were administered EKE by gastric intubation for 15 days. PTU or L-T4 was set as 
positive control. Twenty-four hours after the last administration, all animals were sacrificed by cervical 
dislocation. Blood was collected and serum samples assayed for T3 and T4. Furthermore, the liver was 
removed for biochemical analysis. 
Results: T3 and T4 serum levels in mice decreased after the administration of EKE. The relative 
potency of EKE was calculated in terms of percent increase or decrease in thyroid hormones. 
Compared with the control value, the decrease in T3 concentration by a high dose of EKE was 
approximately 64.32 %. Compared with the control group, hepatic LPO decreased (p < 0.01) while 
superoxide dismutase (SOD, p < 0.01) and catalase (CAT, p < 0.01) activities were significantly 
increased by the high dose of EKE, thus indicating its anti-peroxidative role.  
Conclusion: This suggests that EKE may be useful for the treatment of hyperthyroidism, but further 
studies are required to ascertain this. 
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Two thyroid hormones (thyroxine [T4] and 
triiodothyronine [T3]) are involved in the 
regulation of a myriad of body functions including 
lipid and carbohydrate metabolism, oxygen 
consumption, nerve conduction and reproduction 
[1]. Alterations in their normal levels lead to 
physiological/clinical abnormalities such as 
hypothyroidism and hyperthyroidism. 
 
Despite the fact that day-by-day herbal drugs are 
gaining much importance due to its affordable 
and safe nature, scientific investigations towards 
the mitigation of thyroid disorders via plant 
extracts are meager [2-4]. Therefore, in our 
endeavor to determine a plant extract that can 
regulate the levels of both thyroid hormones, we 
have investigated the potential activities of 
Ecklonia kurome on thyroid functions. Traditional 
Chinese medicine has many advantages in 
treating metabolic disease. Ecklonia kurome is a 
common herb usually used for treating thyroid 
disease.  
 
In this study, the effect of EKE on the efficacy of 
thyroid function was investigated. Hepatic lipid 
peroxidation (LPO), superoxide dismutase (SOD) 
and catalase (CAT) activities were also studied. 
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Plant material and extraction 
 
Ecklonia kurome samples were collected from 
Qingdao City, Shandong Province, China in May 
2016. Taxonomic identification of the plant was 
performed by Professor Liang Lu of Henan 
University of Traditional Chinese Medicine in 
China. A voucher specimen (no. EKE 20160503) 
was deposited in the herbarium of the College of 
Pharmacy, Henan University of Traditional 
Chinese Medicine, China for future reference. 
 
The whole Ecklonia kurome plant was dried in a 
drying oven at 100 °C for 12 hours. The Ecklonia 
kurome aqueous extract was obtained by 
steeping the dried Ecklonia kurome in water at 
60 °C three times, each for one hour before first 
drying in an oven and freeze-drying the last 
extract. One gram of powder was obtained from 
approximately 1.6 g of dried sample; that is, a 
yield of 62.5 %. 
 
Animals and groups 
 
Colony-bred healthy Swiss albino male mice (30 
± 2 g) were purchased from the Experimental 
Animal Center of Henan Province (Certificate no. 
SYXK 2006-02), maintained at 27 ± 1°C with a 
light/dark schedule (14 hours light/10 hours 
dark), and provided with food and water ad 
libitum. These mice were randomly assigned to 
six groups: normal control group, propylthiouracil 
(PTU, 3 mg/kg) group, L-tyroxine (L-T4, 0.5 
mg/kg) group, and various concentrations of 
Ecklonia kurome extract (EKE; 80, 160 and 320 
mg/kg) group.  
 
The animals were administered EKE, PTU, or L-
T4 by gastric intubation. All the treatments were 
given twice daily and continued for 15 days. The 
experiment was approved by the Animal Care 
and Use Committee of Henan University of 
Science and Technology (Approval ref. no. 
20101005) and was carried out in compliance 
with Directive 2010/63/EU on the handling of 




On the last day of the experiment, mice were 
sacrificed by cervical dislocation. Blood was 
collected and serum samples were stored at -80 
°C for one day until assayed for T3 and T4. The 
liver was quickly removed and washed 
thoroughly with phosphate-buffered saline (PBS, 





LPO was estimated by TBA reaction with 
malondialdehyde (MDA), a product formed due 
to the peroxidation of membrane lipids, according 
to the method performed by Ohkawa et al [6], 
and as modified by Jamall and Smith [7]. LPO 
was expressed as nM of MDA formed as per 
h/mg of protein. Hepatic SOD activity was 
assayed according to the method reported by 
Marklund and Marklund [8]. Enzyme activity was 
expressed as units/mg of protein, and one unit of 
enzyme is defined as the activity that inhibits the 
autoxidation of pyrogallol by 50 %. CAT activity 
was estimated following the method reported by 
Aebi [9]. 
 
Determination of thyroid hormones 
 
Serum concentrations of total T3 and T4 were 
estimated by radioimmunoassay, as per routine 
protocol. Lower limits of sensitivity for T3 and T4 
were 0.07 and 0.12 ng/mL, respectively. Inter-




All the data were analyzed using Statistical 
Package SPSS 16.0 (SPSS Inc., Illinois, 
Chicago, USA) and were expressed as mean ± 
standard error of the mean (SEM). These data 
were analyzed by one-way analysis of variance 
(ANOVA) followed by Dunnett’s t-test. A p-value 




Effect of EKE on serum concentrations of T3 
and T4 
 
Compared with the control value, serum T3 and 
T4 concentrations in mice significantly decreased 
when treated by middle and high doses of EKE 
(p < 0.05), while serum T3 and T4 concentrations 
of mice significantly decreased when treated by 
middle and high doses of EKE (p < 0.01). 
Thyroid hormone concentrations also decreased 
in PTU and increased in T4 treated groups (p 
</0.01, for all groups).  
 
When relative potencies of different doses of 
EKE with respect to control values were 
calculated, the maximum inhibition in T3 
concentration was observed by a high dose of 
EKE (64.32 %), followed by a middle dose of 
EKE (32.43 %); while T4 was inhibited by 32.67 
% by a high dose of EKE. Middle doses of EKE 
increased T4 concentrations by 15.41 % (Table 
1). 
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Change in T3 
concentration 
(%) 
Change in T4 
concentration 
(%) 
Control - 1.85 ± 0.14 42.12 ± 2.5 - - 
EKE-L 80 1.63 ± 0.21 40.27 ± 3.3 -11.89 -4.39 
EKE-M 160 1.21 ± 0.15* 35.63 ± 1.5* -32.43 -15.41 
EKE-H 320 0.66 ± 0.12** 28.36 ± 1.1** -64.32 -32.67 
PTU 3 0.61 ± 0.07** 16.34 ± 0.89** -67.03 -61.21 
T4 0.5 2.67 ± 0.15** 104.59 ± 7.38 +44.32 +148.31 
EKE-L: low dose of EKE; EKE-M: middle dose of EKE; EKE-H: high dose of EKE. **P < 0.01, *p < 0.05, compared 
to the respective controls 
 




LPO (nM /mg protein) SOD (unit/mg 
protein) 
CAT (mmol /mg 
protein) 
Control - 0.93 ± 0.07 4.88 ± 0.18 39.26 ± 2.35 
EKE-L 80 0.84 ± 0.05 5.12 ± 0.23 41.25 ± 2.12 
EKE-M 160 0.71 ± 0.06* 6.36 ± 0.21* 45.18 ± 1.95* 
EKE-H 320 0.52 ± 0.04** 8.34 ± 0.17** 57.24 ± 1.84** 
PTU 3 0.97 ± 0.09 4.92 ± 0.19 25.33 ± 3.62** 
T4 0.5 2.37 ± 0.19** 4.53 ± 0.17 34.12 ± 3.27 
EKE-L: low dose of EKE; EKE-M: middle dose of EKE; EKE-H: high dose of EKE. **P < 0.01, *p < 0.05, compared 
to the respective control values 
 
Effect of EKE on hepatic LPO, CAT and SOD 
activities in male mice 
 
The hepatic LPO level of mice decreased when 
treated by high (P</0.01) and middle (P</0.05) 
doses of EKE. On the other hand, SOD and CAT 
activities were significantly enhanced in high 
dose EKE (P<0.01) and middle dose EKE 
(P<0.05, for both) treated animals. In PTU 
treated animals, CAT activity was inhibited 




These results reveal that serum levels of both 
T3and T4 were inhibited by EKE. When the 
relative potency of EKE was calculated in terms 
of percent increase or decrease in thyroid 
hormones, as compared to the control value, the 
decrease in T3 concentration through high doses 
of EKE was approximately 64.32 %. This 
indicates its possible use in the regulation of 
hyperthyroidism. 
 
The predominant thyroidal hormone in circulation 
is T4, while T3 is mostly generated from T4 in 
peripheral tissues by outer ring mono-
deiodination [10,11]. Since only T4, and not T3, 
was enhanced by EKE, it appears that EKE 
might be stimulating the synthesis and/or release 
of T4 directly at the glandular level, and not 
through the peripheral conversion of T4 to T3. 
The former one appeared to have a better 
potency, as it could inhibit T3 by approximately 
64.32 %; which is comparable to that of a 
standard drug, PTU. Although EKE decreased 
both T3 and T4 concentrations, the inhibition was 
only approximately 64 and 32 %, respectively. 
This indicate that EKE may not be very effective 
in the reduction of thyroid hormone 
concentrations. However, EKE may be a better 
choice for thyroid disease, as it does not exhibit 
any hepatotoxic effect, and is rather 
hepatoprotective in nature. 
 
It was reported that LPO occurs in biological 
membranes with potential injurious 
consequences [12,13]. Anti-oxidative enzymes 
(SOD and CAT) usually help maintain cellular 
integrity by protecting it against the deleterious 
effects of lipid peroxides [14]. Interestingly no 
hepatotoxic effects were observed in EKE. The 
decrease in hepatic LPO with a concomitant 
increase in the activities of antioxidative enzymes 





EKE may augment thyroid function, and can 
potentially be developed as a therapeutic agent 
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